Home / Resources (page 830)

Resources

RESOURCES

New Product: Amturnide

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) from Novartis is a medication in tablet form for the treatment of high blood pressure. Amturnide combines the direct renin inhibitor Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

Read More »

A Year of Diabetes Research 2010

Prevention, therapy and complications are the keystones for diabetes research. It would be impossible to cover all of the developments in just one feature. So here is a brief summary of some of the best for 2010.

Read More »

Lilly Applies for Expanded Use of BYETTA® with Basal Insulin

A supplemental New Drug Application (sNDA) has been submitted to the FDA for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with Type 2 diabetes….

Read More »